Skip to main content
| News

«We will show the new product at the Olympic Games 2021 in Tokyo»

15.12.2020

The new Basel Area Business & Innovation Podcast offers exciting conversations with interesting interview partners. The first guest is surgeon and entrepreneur Hans-Florian Zeilhofer. The Bavarian has lived and worked in Basel for 18 years. He has founded various startups and initiated many research projects in the high-tech sector. One of them will be presented at the Olympic Games in Tokyo «as a new product from the Basel Area for the world», as Zeilhofer reveals in the podcast.

Zeilhofer got the idea for his latest project a few months ago when he visited the Humard company in the canton of Jura. «I realized that they had developed a technology for the watchmaking industry which could easily be transformed for educating young surgeons.» Because the product will be shown as a world premiere next year at the Olympic Games in Tokyo, Zeilhofer cannot go into details. But he reveals that it can bring new aspects of automatization into the operating room. And he announces that he has more plans for the Olympics.

Hans-Florian Zeilhofer combines research and entrepreneurship in an exemplary way. In the podcast, he talks about his desire to be a scientist and an entrepreneur at the same time. He also explains what he focuses on when putting together a team. «I like people who are honest, I like people who have passion. These are the most important things I look at,» says Zeilhofer.

Zeilhofer is raving when he talks about the Basel Area as a business and innovation location. He particularly appreciates the short distances, the proximity to the border and the dynamic ecosystem. «The Basel Area is great, not only by size, also by spirit.»

The new podcast sets a stage for the Basel Area. What makes the Basel Area a good business and innovation location? Which innovations could cause a sensation? What is important to consider when founding a startup? Are good scientists also good CEOs? Such questions are discussed with the guests in the Basel Area Business & Innovation Podcast. The episode with Hans-Florian Zeilhofer is available in both German and English. You can subscribe to the Basel Area Business & Innovation Podcast on your preferred platform, for example on Spotify, Deezer, Apple Podcast and Google Play or on baselarea.swiss/media.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Gamma Technologies acquires ProFEMAG portfolio
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Read More
Databaum establishes headquarters in Basel
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...

Read More
Clinerion launches patient information platform
Basel Area Business & Innovation, Digital Health, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...

Read More
New innovation campus opens in the Basel Area
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...

Read More
Sumitovant acquires all shares in Myovant
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Sumitovant acquires all shares in Myovant

Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by acquiring a 100 percent shareholding...

Read More
VectivBio raises 125 million US dollars in stock sale
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

VectivBio raises 125 million US dollars in stock sale

VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The Basel-based biotechnology firm has generated gross...

Read More
1 2 3 29

Do you have a question? We'd like to hear from you.